Merrimack Pharmaceuticals reported $214.1M in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
Bioline Rx USD 16M 40M Sep/2025
Brainstorm Cell Therapeutics USD 8M 3M Sep/2025
Celldex Therapeutics USD 2.21B 99M May/2026
Incyte USD 21.73B 3B May/2026
Roche Holding CHF 266.34B 55.46B Dec/2025